MARKET WIRE NEWS
  1. Home
  2. Stock
  3. XBI
  4. News
  5. Labd Etf To Benefit From Downturns In The Biotech In
XBI
Quote
Short
News
Articles
Message Board

LABD: ETF To Benefit From Downturns In The Biotech Industry

Source: SeekingAlpha

2026-01-26 09:19:21 ET

Fast Facts About the Direxion Daily S&P Biotech Bear 3x Shares ETF

Read the full article on Seeking Alpha

For further details see:

LABD: ETF To Benefit From Downturns In The Biotech Industry
SPDR Series Trust S&P Biotech

NASDAQ: XBI

XBI Trading

-0.93% G/L:

$121.85 Last:

5,802,368 Volume:

$123.43 Open:

mwn-link-x Ad 300

XBI Latest News

February 11, 2026 10:11:00 am
Biotech Beat Nvidia in 2025. Can It Do It Again?
February 11, 2026 09:35:00 am
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
November 17, 2025 09:18:00 pm
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge.
September 11, 2025 05:00:00 am
As the Fed Pivots, These 3 ETFs Are Positioned to Outperform

XBI Stock Data

$7,832,883,000
62,225,000
N/A
N/A
US

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App